Cryoanesthesia for Intravitreal Injections

Completed · Phase 1/Phase 2

Conditions studied: Ocular Anesthesia

In brief

The cryoanesthesia (CA) device is designed to provide anesthesia to a focal area on the surface of the eye immediately prior to intraocular injections. The investigators plan to carry out a pilot study to collect preliminary data on the effectiveness of the cryoanesthesia (CA) device in minimizing the pain caused by intravitreal injections (IVT).

Key facts

Study ID

NCT02872012

Run by

University of Michigan

People needed

23

Starts

2016-03-01

Expected to finish

2018-06-01

Last updated by the study team

2019-09-17

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Bilateral macular disease due to either exudative macular degeneration or diabetic retinopathy requiring bilateral intravitreal injections
• Have had at least one prior intravitreal injection
• Able to give informed consent

You may not qualify if…

• Unilateral disease
• Unable to provide consent
• Preexisting conjunctival, episcleral or scleral defects or disease

Where it is running

• Kellogg Eye Center — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.